World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0003220480
Reproduction Date:

Title: Relaxin  
Author: World Heritage Encyclopedia
Language: English
Subject: Pelvic girdle pain, List of MeSH codes (D06), Cholecystokinin, List of human hormones, Endocrine system
Publisher: World Heritage Encyclopedia


Relaxin 1
Symbol RLN1
Alt. symbols H1
Entrez 6013
HUGO 10026
OMIM 179730
RefSeq NM_006911
UniProt P04808
Other data
Locus Chr. 9 qter-q12
Relaxin 2
Symbol RLN2
Alt. symbols H2, RLXH2, bA12D24.1.1, bA12D24.1.2
Entrez 6019
HUGO 10027
OMIM 179740
RefSeq NM_134441
UniProt P04090
Other data
Locus Chr. 9 qter-q12
Relaxin 3
Symbol RLN3
Alt. symbols ZINS4, RXN3, H3
Entrez 117579
HUGO 17135
OMIM 606855
RefSeq NM_080864
UniProt Q8WXF3
Other data
Locus Chr. 19 p13.3

Relaxin is a protein hormone of about 6000 Da[1] first described in 1926 by Frederick Hisaw.[2][3]

The relaxin-like peptide family belongs in the insulin superfamily and consists of 7 peptides of high structural but low sequence similarity; relaxin-1 (RLN1), 2 (RLN2) and 3 (RLN3), and the insulin-like (INSL) peptides, INSL3, INSL4, INSL5 and INSL6. The functions of relaxin-3, INSL4, INSL5, INSL6 remain uncharacterised.[4]


  • Synthesis 1
  • Structure 2
  • Function 3
    • In humans 3.1
    • In other animals 3.2
  • Receptors 4
  • Disorders 5
  • Pharmacological targets 6
  • See also 7
  • References 8
  • External links 9


In the female, it is produced by the corpus luteum of the ovary, the breast and, during pregnancy, also by the placenta, chorion, and decidua.

In the male, it is produced in the prostate and is present in human semen.[5]


Structurally, relaxin is a heterodimer of two peptide chains of 24 and 29 amino acids linked by disulfide bridges, and it appears related to insulin.

Relaxin is produced from its prohormone, "prorelaxin", by splitting off one additional peptide chain.


In humans

In females relaxin is produced mainly by the corpus luteum, in both pregnant [1] and nonpregnant[1] females; it rises to a peak within approximately 14 days of ovulation, and then declines in the absence of pregnancy, resulting in menstruation ). During the first trimester of pregnancy, levels rise and additional relaxin is produced by the decidua. Relaxin's peak is reached during the 14 weeks of the first trimester and at delivery. It is known to mediate the hemodynamic changes that occur during pregnancy, such as increased cardiac output, increased renal blood flow, and increased arterial compliance. It also relaxes other pelvic ligaments.[6] It is believed to soften the pubic symphysis.

In males, relaxin enhances motility of sperm in semen.[7]

In other animals

In animals, relaxin widens the pubic bone and facilitates labor; it also softens the cervix (cervical ripening), and relaxes the uterine musculature. Thus, for a long time, relaxin was looked at as a pregnancy hormone. However, its significance may reach much further. Relaxin affects collagen metabolism, inhibiting collagen synthesis and enhancing its breakdown by increasing matrix metalloproteinases.[8] It also enhances angiogenesis and is a potent renal vasodilator.


Relaxin interacts with the relaxin receptor LGR7 (RXFP1) and LGR8 (RXFP2), which belong to the G protein-coupled receptor superfamily.[9] They contain a heptahelical transmembrane domain and a large glycosylated ectodomain, distantly related to the receptors for the glycoproteohormones, such as the LH-receptor or FSH-receptor.

Relaxin receptors have been found in the heart, smooth muscle, the connective tissue, and central and autonomous nervous system.


Specific disorders related to relaxin have not been described, yet a link to scleroderma and fibromyalgia has been suggested.[10] it may also have other disorders

Pharmacological targets

A recombinant form of human relaxin-2 has been developed as investigational drug RLX030 (serelaxin).

See also


  1. ^ a b c Bani D (January 1997). "Relaxin: a pleiotropic hormone.". General pharmacology 28 (1): 13–22.  
  2. ^ "If a Gopher Can Do It ...". Time Magazine. 1944-04-10. Retrieved 2009-05-20. 
  3. ^ Becker GJ, Hewitson TD (March 2001). "Relaxin and renal fibrosis". Kidney Int. 59 (3): 1184–5.  
  4. ^ Wilkinson TN, Speed TP, Tregear GW, Bathgate RA (February 2005). "Evolution of the relaxin-like peptide family". BMC Evolutionary Biology 5: 14.  
  5. ^ MacLennan AH (1991). "The role of the hormone relaxin in human reproduction and pelvic girdle relaxation". Scandinavian journal of rheumatology. Supplement 88: 7–15.  
  6. ^ Conrad KP (August 2011). "Maternal vasodilation in pregnancy: the emerging role of relaxin". Am. J. Physiol. Regul. Integr. Comp. Physiol. 301 (2): R267–75.  
  7. ^ Weiss G (February 1989). "Relaxin in the male". Biol. Reprod. 40 (2): 197–200.  
  8. ^ Mookerjee I, Solly NR, Royce SG, Tregear GW, Samuel CS, Tang ML (2006). "Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease". Endocrinology 147 (2): 754–61.  
  9. ^ Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ (2002). "Activation of orphan receptors by the hormone relaxin". Science 295 (5555): 674–6.  
  10. ^ Van Der Westhuizen ET, Summers RJ, Halls ML, Bathgate RA, Sexton PM (2007). "Relaxin receptors--new drug targets for multiple disease states". Curr Drug Targets 8 (1): 91–104.  

External links

  • Relaxin at the US National Library of Medicine Medical Subject Headings (MeSH)
  • "Relaxin". Human Protein Reference Database. Johns Hopkins University and the Institute of Bioinformatics. Retrieved 2009-05-20. 
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.